Insulin glargine and lixisenatide Subcutaneous and Prucalopride Succinate
Determining the interaction of Insulin glargine and lixisenatide Subcutaneous and Prucalopride Succinate and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: insulin glargine / lixisenatide
Brand name: Soliqua 100/33
Synonyms: Insulin glargine and lixisenatide (Subcutaneous)
Generic Name: prucalopride
Brand name: Motegrity
Synonyms: Prucalopride
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Insulin glargine and lixisenatide Subcutaneous-Prudoxin
- Insulin glargine and lixisenatide Subcutaneous-Prudoxin Topical
- Insulin glargine and lixisenatide Subcutaneous-Pryflex
- Insulin glargine and lixisenatide Subcutaneous-Pseudodine C
- Insulin glargine and lixisenatide Subcutaneous-Pseudoephedrine
- Insulin glargine and lixisenatide Subcutaneous-Pseudoephedrine and Codeine
- Prucalopride Succinate-Insulin glargine, recombinant Subcutaneous
- Prucalopride Succinate-Insulin glulisine
- Prucalopride Succinate-Insulin Glulisine (Cartridges and Pens)
- Prucalopride Succinate-Insulin Glulisine (Vials)
- Prucalopride Succinate-Insulin glulisine Subcutaneous
- Prucalopride Succinate-Insulin human inhaled Inhalation